University of Texas MD Anderson Cancer Center

Hospital


Location: Houston, United States (USA) (US) US

ISNI: 0000000122914776

ROR: https://ror.org/04twxam07

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Consensus on molecular imaging and theranostics in neuroendocrine neoplasms (2021) Ambrosini V, Kunikowska J, Baudin E, Bodei L, Bouvier C, Capdevila J, Cremonesi M, et al. Journal article, Review article Germline variation in the insulin-like growth factor pathway and risk of Barrett's esophagus and esophageal adenocarcinoma (2021) Dighe SG, Chen J, Yan L, He Q, Gharahkhani P, Onstad L, Levine DM, et al. Journal article Treatment-related amenorrhea with T-DM1 plus pertuzumab (KP) is lower than with docetaxel/carboplatin/ trastuzumab/pertuzumab (TCHP) in the phase III neoadjuvant KRISTINE trial (2021) Hurvitz SA, Fresco R, Afenjar K, Stroyakovskiy D, Huang CS, Wildiers H, Jung KH, et al. Conference contribution Markers of Systemic Inflammation in Neuroendocrine Tumors: A Pooled Analysis of the RADIANT-3 and RADIANT-4 Studies (2021) Chan DL, Yao JC, Carnaghi C, Buzzoni R, Herbst F, Ridolfi A, Strosberg J, et al. Journal article Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia (2021) Trpkov K, Williamson SR, Gill AJ, Adeniran AJ, Agaimy A, Alaghehbandan R, Amin MB, et al. Journal article T-Cell immune surveillance in allogenic stem cell transplant recipients: Are whole blood-based assays ready to challenge ELISPOT? (2021) Lauruschkat CD, Page L, Etter S, Weis P, Gamon F, Kraus S, Einsele H, et al. Journal article Physicians' Opinion and Practice With the Continuous Use of Sedatives in the Last Days of Life (2021) Heijltjes MT, Morita T, Mori M, Heckel M, Klein C, Stiel S, Miccinesi G, et al. Journal article Association of quality of life (QOL) with overall survival (OS) in patients (pts) with HR+/HER2-advanced breast cancer (ABC) treated with ribociclib (RIB) plus endocrine therapy (ET) in the MONALEESA-3 (ML-3) and ML-7 trials (2021) Fasching P, Harbeck N, Jerusalem G, Colleoni MA, Neven P, Franke F, De Laurentiis M, et al. Conference contribution The phase III NETTER-1 study of 177Lu-DOTATATE in patients with midgut neuroendocrine tumours: Further survival analyses (2021) Ruszniewski PB, Caplin ME, Kunz PL, Bodei L, Hendifar AE, Mittra E, Wolin EM, et al. Conference contribution Artificial hyperventilation normalizes haemodynamics and arterial oxygen content in hypoxic rats (2021) De Villalobos D, Laserna A, Fowler C, Cuenca JA, Martin P, Guindani M, Dong W, et al. Journal article